FDA Pushes Back Rule On Generic-Drug Warning Labels
The U.S. Food and Drug Administration on Tuesday said it doesn't expect to finalize a proposal to let generic-drug makers unilaterally update their warning labels until late next year, a setback...To view the full article, register now.
Already a subscriber? Click here to view full article